Publications by authors named "D M Zuo"

Atopic dermatitis (AD) is a prevalent chronic inflammatory skin disorder characterized by intense pruritus and complex immunopathogenic mechanisms. Recent evidence has highlighted the critical link between dysregulated intestinal microecology and altered immune responses in AD progression. As essential components of the intestinal microenvironment, metabolites play pivotal roles in various physiological processes.

View Article and Find Full Text PDF

Hydrides in metal complexes or nanoclusters are typically viewed as electron-withdrawing. Several recent reports have demonstrated the emergence of "electron-donating" hydrides in tailoring the structure, electronic structure, and reactivity of metal nanoclusters. However, the number of such hydrides included in each cluster kernel is limited to one or two.

View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDAC) is characterized by its aggressive nature and dismal prognosis, largely attributed to its unique tumor microenvironment. However, the molecular mechanisms by which tumor-associated macrophages (TAMs) promote PDAC progression, particularly the role of β-catenin signaling in regulating TAM phenotype and function, remain incompletely understood. Initially, we performed comprehensive analyses of RNA-seq and single-cell RNA-seq (scRNA-seq) datasets to investigate OSM and LOXL2 expression patterns in PDAC.

View Article and Find Full Text PDF

Asymmetric supercapacitors (ASCs), which combine the advantages of electric double-layer capacitors and pseudocapacitors, have attracted more and more research interest. However, the performance of water-based ASCs often faces the challenge of electrolyte freezing at low temperatures. To resolve the problem, a ternary deep eutectic solvent (DES) with an eutectic point of less than -100 °C was first prepared.

View Article and Find Full Text PDF
Article Synopsis
  • RPN1 is a transmembrane protein that is abnormally expressed in triple-negative breast cancer (TNBC), leading to faster tumor growth and poorer outcomes.
  • RPN1 enhances the stability and glycosylation of PD-L1, which helps tumors evade the immune system, and its removal could improve the effectiveness of anti-PD-1 therapies in TNBC.
  • This study also highlights a new regulatory pathway involving the transcription factor YY1 in influencing RPN1 and PD-L1 interaction, suggesting that targeting RPN1 could serve as a promising immunotherapy approach for treating TNBC.
View Article and Find Full Text PDF